Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy (Q32054917)

6 July 2017

Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy (English)

1 reference

6 July 2017

0 references

dilated cardiomyopathy

1 reference

Ohtsuka T

1

1 reference

6 July 2017

Hamada M

2

1 reference

6 July 2017

Hiasa G

3

1 reference

6 July 2017

Sasaki O

4

1 reference

6 July 2017

Suzuki M

5

1 reference

6 July 2017

Hara Y

6

1 reference

6 July 2017

Shigematsu Y

7

1 reference

6 July 2017

Hiwada K

8

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Journal of the American College of Cardiology

6 July 2017

1 reference

6 July 2017

37

1 reference

6 July 2017

412-417

1 reference

6 July 2017

2

1 reference

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

6 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Expression and functional significance of tumor necrosis factor receptors in human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Anti-inflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Blood pressure response to the Valsalva maneuver in pheochromocytoma and pseudopheochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-I, natriuretic peptides and noradrenaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901121-9

7 January 2021

10.1016/S0735-1097(00)01121-9

Identifiers

DOI

1 reference

6 July 2017

1 reference